CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Coastlands Capital LP 10% owner | Purchase | +50,000 | $6.38 | $319K | 462,416 |
| 2026-10-23 | GUJRATHI SHEILA Chief Strategy Officer | Grant or award | +72,766 | 72,766 | ||
| 2026-10-23 | GUJRATHI SHEILA Chief Strategy Officer | Grant or award | +13,055 | 13,055 | ||
| 2026-10-23 | GUJRATHI SHEILA Chief Strategy Officer | Other acquisition · Series D Preferred Stock | +2,763.83 | 2,763.83 | ||
| 2026-10-23 | GUJRATHI SHEILA Chief Strategy Officer | Other acquisition · Series D Preferred Stock | +495.87 | 495.87 | ||
| 2026-09-18 | Yonehiro Grant Chief Operating Officer | Sale | −6,850 | $3.24 | $22K | 17,269 |
| 2026-09-18 | Nemec Sarah Senior VP, Finance and PAO | Sale | −4,077 | $3.24 | $13K | 17,082 |
| 2026-09-18 | Quinn William P. President, CEO and CFO | Sale | −9,132 | $3.24 | $30K | 25,384 |
| 2026-09-17 | Yonehiro Grant Chief Operating Officer | Sale | −4,909 | $3.32 | $16K | 24,119 |
| 2026-09-17 | Nemec Sarah Senior VP, Finance and PAO | Sale | −2,922 | $3.32 | $10K | 21,159 |
| 2026-09-17 | Quinn William P. President, CEO and CFO | Sale | −6,545 | $3.32 | $22K | 34,516 |
| 2026-09-16 | Yonehiro Grant Chief Operating Officer | Sale | −1,417 | $3.77 | $5K | 29,028 |
| 2026-09-16 | Nemec Sarah Senior VP, Finance and PAO | Sale | −843 | $3.77 | $3K | 24,081 |
| 2026-09-16 | Quinn William P. President, CEO and CFO | Sale | −1,889 | $3.77 | $7K | 41,061 |
| 2026-06-10 | Berner Laura Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2026-06-10 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2026-06-10 | Dupont Jakob Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2026-06-10 | O'CALLAGHAN BRIAN Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2026-06-10 | ONETTO NICOLE Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2026-06-05 | Nemec Sarah Senior VP, Finance and PAO | Purchase | +509 | $3.88 | $2K | 1,924 |
Page 1 of 17 · 337 trades